Quantcast
Last updated on April 20, 2014 at 8:28 EDT

Latest epilepsy Stories

2013-10-02 23:26:53

Multi-disciplinary TSC Center to Provide Greater Access and Quality of Care to TSC Patients throughout the Midwest Chicago, IL (PRWEB) October 02, 2013 Bcureful®—a non-profit organization whose mission is to accelerate research towards a cure for Tuberous Sclerosis Complex (TSC)—presented its inaugural donation in the amount of $20,000.00 to launch the new Tuberous Sclerosis Complex Center at Ann & Robert H. Lurie Children’s Hospital of Chicago. Lurie Children’s is...

2013-09-27 23:03:52

Everolimus Drug Study with TSC Patients to Measure Impact on Brain New York, NY (PRWEB) September 27, 2013 Bcureful® presented a check in the amount of $15,000.00 to Dr. Orrin Devinsky, Director of the Comprehensive Epilepsy Center at NYU Langone Medical Center, for his upcoming everolimus research project. Bcureful Board members Lori Nerheim of Chicago and Laurie Marshall of New York City presented the check to Dr. Devinsky. “Now is one of the most exciting times in TSC...

2013-09-25 08:30:42

SAN DIEGO, Sept. 25, 2013 /PRNewswire-USNewswire/ -- Current estimates indicate that autism spectrum disorder affects 1 in 88 children, and that the incidence of this disorder is continuing to rise. Medical abnormalities associated with autism are being increasingly recognized. Seizures affect a substantial portion; some estimates suggest that up to 1/3 of children with autism may eventually develop seizures. The incidence of seizures appears to increase with age, becoming more...

2013-09-24 10:16:27

Prenatal exposure to antiepileptic medications was associated with an increased risk of impaired fine motor skills (small muscle movements) in children at age 6 months, but breastfeeding by women taking the medications was not associated with any harmful effects on child development at ages 6 to 36 months, according to a report published by JAMA Neurology, a JAMA Network publication. Few studies have examined development during the first months of life of children of mothers with epilepsy,...

2013-09-23 08:25:03

Two Peer-Reviewed Papers Featured in October Issue of Pediatric Neurology SILVER SPRING, Md., Sept. 23, 2013 /PRNewswire-USNewswire/ -- Today, the Tuberous Sclerosis Alliance (TS Alliance) formally announced newly updated clinical consensus guidelines for the diagnosis, surveillance and management of tuberous sclerosis complex (TSC). To communicate the recommendations to healthcare professionals, the October issue of Pediatric Neurology includes two peer-reviewed papers detailing the...

2013-09-18 23:29:56

Adam Casner, an experienced Social Security Disability attorney with Heard & Smith has been invited to deliver a presentation at the Epilepsy Foundation of Central and South Texas in Austin on September 25, 2013 starting at 6:30 pm. San Antonio, TX (PRWEB) September 18, 2013 Adam Casner, an experienced Social Security Disability attorney with Heard & Smith, a national disability law firm that concentrates on the disabled and the injured, has been invited to deliver a presentation...

2013-09-18 08:30:03

MISSISSAUGA, ON, Sept. 18, 2013 /CNW/ - Sunovion Pharmaceuticals Canada Inc. (Sunovion) today announced that Health Canada has accepted for review the company's New Drug Submission (NDS) for eslicarbazepine acetate for use as a once-daily adjunctive therapy in the treatment of partial-onset seizures in patients 18 years of age and older with epilepsy. The efficacy and safety of eslicarbazepine acetate as an adjunctive or monotherapy treatment for partial-onset seizures in adults...

2013-09-18 04:22:35

LONDON, Sept. 18, 2013 /PRNewswire/ -- GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, "GW") announced today it has commenced a Phase 1 clinical trial of product candidate GWP42006 for the treatment of epilepsy. Over the last five years, GW has conducted an extensive pre-clinical cannabinoid research program in the field of epilepsy in collaboration with the University of Reading in the United Kingdom. This research has led to the emergence of a number of promising cannabinoid...

2013-09-17 23:33:23

As The Wall Street Journal published on August 22, Dr. Reddy's launched a generic version of Depakote ER with a warning for life-threatening adverse reactions. In light of this news, AttorneyOne, a recognized authority on law, informs that they are now providing advice, including how to get in contact with legal counsel, to people potentially affected by Depakote side effects. San Diego, CA (PRWEB) September 17, 2013 AttorneyOne.com, a recognized authority on law, updated the website...

2013-09-05 11:33:40

New research suggests that men who exercise vigorously as young adults may reduce their risk of developing epilepsy later in life. The study is published in the September 4, 2013, online issue of Neurology®, the medical journal of the American Academy of Neurology. Epilepsy is a brain disease that causes repeated seizures over time. "There are a host of ways exercise has been shown to benefit the brain and reduce the risk of brain diseases," said study author Elinor Ben-Menachem, PhD, MD,...